Woodline Partners’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.46M | Buy |
400,504
+100,000
| +33% | +$1.86M | 0.04% | 486 |
|
|
2025
Q1 | $5.45M | Hold |
300,504
| – | – | 0.04% | 484 |
|
|
2024
Q4 | $6.55M | Buy |
300,504
+50,000
| +20% | +$1.09M | 0.04% | 429 |
|
|
2024
Q3 | $6.86M | Buy |
250,504
+171
| +0.1% | +$4.68K | 0.06% | 346 |
|
|
2024
Q2 | $6.48M | Buy |
+250,333
| New | +$6.48M | 0.06% | 306 |
|
|
2022
Q4 | – | Sell |
-81,559
| Closed | -$1.84M | – | 777 |
|
|
2022
Q3 | $1.84M | Buy |
81,559
+23,235
| +40% | +$524K | 0.03% | 475 |
|
|
2022
Q2 | $1.12M | Buy |
58,324
+8,545
| +17% | +$164K | 0.02% | 503 |
|
|
2022
Q1 | $2.31M | Buy |
49,779
+33,249
| +201% | +$1.54M | 0.04% | 363 |
|
|
2021
Q4 | $1.17M | Sell |
16,530
-15,699
| -49% | -$1.11M | 0.02% | 492 |
|
|
2021
Q3 | $3.75M | Buy |
+32,229
| New | +$3.75M | 0.06% | 298 |
|